Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Wuhan General Group (China) Inc WUHN

Healthcare Drug Manufacturers - Specialty & Generic
Wuhan General Group (China) Inc is a South Africa-based bioceutical company. The Company is focused on alternative plant-based cannabinoids and mental health therapeutic research. Through its subsidiary, Neur.ai, the Company is engaged in developing a portfolio of receptor agonists based on neurotransformational medicine for the treatment of mental illness. The Company develops and... see more

Recent & Breaking News (GREY:WUHN)

Dr. Southey and Dr. Zarrebini Join M2Bio Sciences and Establish M2Bio Blockchain Research and Technology Group

Accesswire August 19, 2021

Wuhan General Group Launches M2Bio Labs in Hout Bay, South Africa

Accesswire August 16, 2021

Wuhan General Group Updates on Third Scientific Paper Published on Psychedelics

Accesswire August 5, 2021

M2Bio Sciences Food and Beverage Launches CBD Sachets

Accesswire July 21, 2021

Liviana CBD Infused Extra Virgin Olive Oil E-Commerce Now Open for Business

Accesswire July 6, 2021

Wuhan Sciences Launches the M2Bio Surfboard NFT Collection

Accesswire June 29, 2021

Lesotho Government Supports M2Bio Sciences Blockchain Initiatives

Accesswire June 2, 2021

Wuhan General Group Appoints Robert "Black Tiger" Simbowe as Director of Health and Fitness

Accesswire May 24, 2021

Wuhan General Group Appoints Michael Sachar CEO of M2Bio Sciences Food & Beverage

Accesswire May 20, 2021

Liviana Artisanal CBD Olive Oils Have Arrived

Accesswire May 7, 2021

Wuhan General Group Secures Lab for Hemp and Mycelium Eco-Friendly Research & Development

Accesswire May 5, 2021

Wuhan General Group Recruiting in Lesotho for its Medicinal Cannabis Cultivation Facility

Accesswire April 20, 2021

Medspresso(TM) Partners with CNC Products for Online Listing and CSR Activities

Accesswire April 14, 2021

Wuhan General Group Introduces Liviana(TM) CBD Infused Artisanal Olive Oil

Accesswire April 9, 2021

CORRECTION: Wuhan Launches Medspresso CBD Infused Whole Bean Roasted Coffee

Accesswire March 23, 2021

Wuhan Launches Medspresso CBD Infused Whole Bean Roasted Coffee

Accesswire March 23, 2021

Wuhan Announces Opening Cape Town Office

Accesswire March 22, 2021

Medspresso Partners up with Zootly: South Africa's Leading Cannabis Destination

Accesswire February 9, 2021

Wuhan General Group Posts FY19 and FY20 Results

Accesswire February 1, 2021

Financier Sheldon Inwentash Joins Wuhan General Group as Strategic Advisor

Accesswire January 27, 2021